Theranica

Theranica is a prescription digital therapeutics company dedicated to creating effective, safe, affordable, and low-side-effect electronic medications for idiopathic pain conditions. The company's award-winning flagship product, Nerivio®, is the first smartphone-controlled prescription wearable device approved by the FDA for treating acute migraine attacks or chronic migraines in individuals aged 12 years and above. Theranica is expanding its patented technology to provide additional solutions for other pain symptoms. Nerivio has received FDA authorization and CE marking for the acute treatment of migraines. By combining neuromodulation therapy with modern wireless technology, proprietary wearable solutions are being developed to address various medical conditions and disease states. Non-invasive and therapeutic "smart" patches are controlled by a smartphone application to enable personalized, portable, and cost-effective care. The patch consists of a proprietary "smart" chip that delivers electrical impulses to modulate sensory nerves beneath the skin. The first application of this technology is for the treatment of migraines.